Nexviazyme Prices, Coupons, Copay Cards & Patient Assistance
Nexviazyme (avalglucosidase alfa) is a member of the lysosomal enzymes drug class and is commonly used for Pompe Disease.
The cost for Nexviazyme ngpt 100 mg intravenous injection is around $1,962 for a supply of 1 injection, depending on the pharmacy you visit. Quoted prices are for cash-paying customers and are not valid with insurance plans. This price guide is based on using the Drugs.com discount card which is accepted at most U.S. pharmacies.
Nexviazyme prices
Intravenous Injection
ngpt 100 mg
Nexviazyme intravenous injection
from $1,962.46
for 1 injection
Quantity | Per unit | Price |
---|---|---|
1 | $1,962.46 | $1,962.46 |
Important: When there is a range of pricing, consumers should normally expect to pay the lower price. However, due to stock shortages and other unknown variables we cannot provide any guarantee.
Drugs.com Printable Discount Card
The free Drugs.com Discount Card works like a coupon and can save you up to 80% or more off the cost of prescription medicines, over-the-counter drugs and pet prescriptions.
Print Free Discount CardNote: This is a drug discount program, not an insurance plan. Valid at all major chains including Walgreens, CVS Pharmacy, Target, WalMart Pharmacy, Duane Reade and 65,000 pharmacies nationwide.
Nexviazyme Coupons, Copay Cards and Rebates
Nexviazyme offers may take the form of printable coupons, rebates, savings or copay cards, trial offers, or free samples. Certain offers may be printable from a website while others may require registration, completing a questionnaire, or obtaining a sample from a medical professional.
Nexviazyme CareConnectPSS Copay Assistance Program
Eligible commercially insured patients may have 100% of eligible out-of-pocket drug costs covered up to the program maximum each calendar year when enrolled in the program.
- Applies to:
- Nexviazyme
- Number of uses:
- Per prescription per calendar year
Form more information phone: 800-745-4447 or Visit website
Nexviazyme QuickStart Program
Eligible commercially insured patients may be provided up to 4 infusions at no charge if they are experiencing a delay in insurance coverage.
- Applies to:
- Nexviazyme
- Number of uses:
- Temporary Assistance
Form more information phone: 800-745-4447 or Visit website
Nexviazyme CareConnectPSS Interim Access Program
Eligible commercially insured patients may receive medication at no cost for up to 6 months if they are experiencing insurance coverage lapses or delays; patient must already be undergoing treatment.
- Applies to:
- Nexviazyme
- Number of uses:
- Temporary Assistance
Form more information phone: 800-745-4447 or Visit website
Patient Assistance & Copay Programs for Nexviazyme
Patient assistance programs (PAPs) are typically sponsored by pharmaceutical companies and offer cost-free or discounted medicines, as well as copay programs, to individuals with low income or those who are uninsured/under-insured and meet specific criteria. Eligibility requirements for each program may vary.
Provider: Patient Access Network Foundation (PAN)
Eligibility requirements:- *See Additional Information section below
- Between 400-500% of FPL
- FDA Approved Diagnosis - See Program Website for Details
- Must reside and receive treatment in US
- *Patients must have health insurance and their insurance must cover the qualifying medication for which they seek assistance. Call for most recent medications as the list is subject to change and the medication for which you are seeking assistance must treat the disease directly. Note: All new enrollment is now done electronically or over the phone. Contact program for details.
- Nexviazyme (avalglucosidase alfa-ngpt) Injection; IV infusion
More information please phone: 866-316-7263 Visit Website
Provider: CareConnect Personalized Support Services (PSS)
Eligibility requirements:- Determined case by case
- Not disclosed
- FDA-approved diagnosis
- Must be treated by US licensed healthcare provider
- Education and support services are available; Contact program for details. CareConnectPSS is designed to support each patient's unique journey to help them overcome challenges related to living with a rare disease (ASMD, Fabry Disease, Gaucher Disease, MPS 1 and Pompe Disease).
- Nexviazyme (avalglucosidase alfa-ngpt) Injection; IV infusion
More information please phone: 800-745-4447 Visit Website
Disclaimer: Medication pricing is sourced from a variety of providers. Pricing may vary significantly due to several factors including brand or generic status, insurance coverage, pharmacy choice, location, and manufacturer pricing policies. Prices are subject to change. For the most accurate and up-to-date information, always consult directly with your pharmacy or healthcare provider.
More about Nexviazyme (avalglucosidase alfa)
- Check interactions
- Compare alternatives
- Drug images
- Side effects
- Dosage information
- During pregnancy
- FDA approval history
- Drug class: lysosomal enzymes
- Breastfeeding
- En español